Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02707406 · ClinicalTrials.gov registry record · NA
Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K
A NA study, sponsored by BioTissue Holdings.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT02707406 is a NA study that has completed, run by BioTissue Holdings. The registered enrollment target is 124 participants.
The verdict
NCT02707406, a NA study, has completed, sponsored by BioTissue Holdings.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
The study is evaluating NEOX®CORD 1K, a cryopreserved human umbilical cord allograft. The purpose of the study is to evaluate the safety, incidence and rate of wound closure following application of the product compared to standard of care in the treatment of difficult to heal diabetic foot ulcers.
Interventions
- OTHER standard of care
- OTHER NEOX®CORD 1K
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02707406
The ClinicalTrials.gov registry entry for NCT02707406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioTissue Holdings, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which standard of care is the first listed.
NCT02707406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02707406 about?
NCT02707406 is a clinical study titled "Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K". The study is evaluating NEOX®CORD 1K, a cryopreserved human umbilical cord allograft. The purpose of the study is to evaluate the safety, incidence and rate of wound closure following application of the product compared to standard of care in the treatment of difficult to heal diabetic foot ulcers.
What is the current status of trial NCT02707406?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2016-02. Estimated completion is 2018-10-09.
What interventions are being tested in trial NCT02707406?
The interventions under investigation include: standard of care (OTHER), NEOX®CORD 1K (OTHER).
Who is sponsoring clinical trial NCT02707406?
This trial is sponsored by BioTissue Holdings, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.